The site is undergoing maintenance on
Thursday, September 10, 7:00 pm through Friday, September 11, 3:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 7:00 pm through Friday, September 11, 3:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 7:00 pm through Friday, September 11, 3:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of human CCR10 expression on peripheral blood lymphocytes. Whole blood was treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899) to lyse erythrocytes. The leucocytes were then stained with Alexa Fluor® 488 Mouse Anti-Human CD3 antibody (Cat No. 557694) and either PE Mouse IgG2a, κ Isotype Control (Cat. No. 554648; Left Panel) or PE Mouse Anti-Human CCR10 (Cat. No. 563656; Right Panel). The two-color flow cytometric dot plot shows the correlated expression patterns of CD3 versus CCR10 (or Ig Isotype control staining) for gated events with the forward and side light-scatter characteristics of viable peripheral blood lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human CCR10 expression on peripheral blood lymphocytes. Whole blood was treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899) to lyse erythrocytes. The leucocytes were then stained with Alexa Fluor® 488 Mouse Anti-Human CD3 antibody (Cat No. 557694) and either PE Mouse IgG2a, κ Isotype Control (Cat. No. 554648; Left Panel) or PE Mouse Anti-Human CCR10 (Cat. No. 563656; Right Panel). The two-color flow cytometric dot plot shows the correlated expression patterns of CD3 versus CCR10 (or Ig Isotype control staining) for gated events with the forward and side light-scatter characteristics of viable peripheral blood lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human CCR10 expression on peripheral blood lymphocytes. Whole blood was treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899) to lyse erythrocytes. The leucocytes were then stained with Alexa Fluor® 488 Mouse Anti-Human CD3 antibody (Cat No. 557694) and either PE Mouse IgG2a, κ Isotype Control (Cat. No. 554648; Left Panel) or PE Mouse Anti-Human CCR10 (Cat. No. 563656; Right Panel). The two-color flow cytometric dot plot shows the correlated expression patterns of CD3 versus CCR10 (or Ig Isotype control staining) for gated events with the forward and side light-scatter characteristics of viable peripheral blood lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human CCR10 expression on peripheral blood lymphocytes. Whole blood was treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899) to lyse erythrocytes. The leucocytes were then stained with Alexa Fluor® 488 Mouse Anti-Human CD3 antibody (Cat No. 557694) and either PE Mouse IgG2a, κ Isotype Control (Cat. No. 554648; Left Panel) or PE Mouse Anti-Human CCR10 (Cat. No. 563656; Right Panel). The two-color flow cytometric dot plot shows the correlated expression patterns of CD3 versus CCR10 (or Ig Isotype control staining) for gated events with the forward and side light-scatter characteristics of viable peripheral blood lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human CCR10 expression on peripheral blood lymphocytes. Whole blood was treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899) to lyse erythrocytes. The leucocytes were then stained with Alexa Fluor® 488 Mouse Anti-Human CD3 antibody (Cat No. 557694) and either PE Mouse IgG2a, κ Isotype Control (Cat. No. 554648; Left Panel) or PE Mouse Anti-Human CCR10 (Cat. No. 563656; Right Panel). The two-color flow cytometric dot plot shows the correlated expression patterns of CD3 versus CCR10 (or Ig Isotype control staining) for gated events with the forward and side light-scatter characteristics of viable peripheral blood lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human CCR10 expression on peripheral blood lymphocytes. Whole blood was treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899) to lyse erythrocytes. The leucocytes were then stained with Alexa Fluor® 488 Mouse Anti-Human CD3 antibody (Cat No. 557694) and either PE Mouse IgG2a, κ Isotype Control (Cat. No. 554648; Left Panel) or PE Mouse Anti-Human CCR10 (Cat. No. 563656; Right Panel). The two-color flow cytometric dot plot shows the correlated expression patterns of CD3 versus CCR10 (or Ig Isotype control staining) for gated events with the forward and side light-scatter characteristics of viable peripheral blood lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 1B5 monoclonal antibody specifically binds to CCR10 (CC-chemokine receptor 10). CCR10 is a seven transmembrane domain G-protein-coupled receptor that is also known as GPR-2 (G-protein coupled receptor 2). CCR10 is expressed by cells that mediate epithelial immunity including a small subset of T memory cells, IgA-secreting B cells, dermal endothelial cells and fibroblasts. It is also expressed on EBV-immortalized B cells. Chemokines CCL27 and CCL28 are the ligands for CCR10. CCR10 reportedly not only functions in regulating the homing and function of cells that mediate epithelial immunity. It may also regulate the epithelial localization, survival, and proliferation of tumor cells and facilitate their evasion from immune surveillance.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.